Key statistics
As of last trade Nutriband Inc (NTRB:NAQ) traded at 4.16, 5.05% above its 52-week low of 3.96, set on Feb 17, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.32 |
|---|---|
| High | 4.32 |
| Low | 4.16 |
| Bid | 4.02 |
| Offer | 4.24 |
| Previous close | 4.31 |
| Average volume | 8.93k |
|---|---|
| Shares outstanding | 12.17m |
| Free float | 3.12m |
| P/E (TTM) | -- |
| Market cap | 54.06m USD |
| EPS (TTM) | -3.07 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 15:44 GMT.
More ▼
- Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
- Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
- Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
- Nutriband CEO Publishes Letter to Shareholders
- Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio
- Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration
- Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
- REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
- Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
- Nutriband Co-Founder Gareth Sheridan Returns as CEO
More ▼
